‘I am still working through my injury and that is the reason I withdrew from Palm Springs, because I have still not healed my injury.
Asked if she knew what the consequences of her failed test may be, Sharapova added: ‘I do not. This is very new for me, I just received the letter a few days ago and I will be working with the ITF.’
The full statement from the ITF made clear Sharapova accepted the charge against her.
It said: ‘Following the statement made by Maria Sharapova in a press conference today, the Tennis Anti-Doping Programme (TADP) can confirm the following:
On 26 January 2016, Ms Sharapova provided an anti-doping sample to the TADP in association with her participation in the 2016 Australian Open.
‘That sample was analysed by a World Anti-Doping Agency (WADA) accredited laboratory, which returned a positive for meldonium, which is a prohibited substance under the WADA Code and, therefore also the TADP.
‘In accordance with Article 8.1.1 of the TADP, Ms Sharapova was charged on 2 March with an Anti-Doping Rule Violation.
‘Ms Sharapova has accepted the finding of meldonium in her sample collected on 26 January.
‘As meldonium is a non-specified substance under the WADA (and, therefore, TADP) list of Prohibited Substances and Prohibited Methods, Ms Sharapova will be provisionally suspended with effect from 12 March, pending determination of the case.’